Posts Tagged ‘obesity’

Much of the world seems stuck on chasing ever higher numbers for weight loss. But clearly we need better targets for innovation in obesity and metabolic health. At the recent BIO Investment & Growth Summit, Immunis CEO Hans Keirstead came to tell us the answer lies in the health of our muscles. He has a […]

Trends for metabolic and bariatric surgery are still wobbly as GLP-1 utilization continues to grow. This much is quite clear from a new research letter in JAMA Surgery. What is less clear is any consensus on where the trends will go as health systems and people living with obesity confront the reality of obesity as […]

“GLP-1s have blown our budget” is an excuse we hear for cutting people off from getting care. Fair enough. The costs for obesity treatment need to come down. But a growing body of evidence tells us it would be a serious mistake to overlook the economic benefits of treating obesity. In fact, a recent study in […]

This has been a long time coming and the path to get here has been tortured. Nature Medicine published new results of a rigorous phase two study with bimagrumab and semaglutide for obesity. The results are striking because the combination of these two drugs produces improvements in body composition we have never seen before in […]

The world has moved from being flat out mistaken about obesity to persistent global confusion about it. This picture emerges from an impressive research project by the survey research firm known as Ipsos. 14,500 People Across 14 Countries Recognizing the importance of World Obesity Day, Ipsos fielded a global survey of 14,500 people in 14 […]

Neglect is a strong word. But if we want to be honest about the excessive emphasis on weight loss in obesity care, it seems appropriate. Research on new therapies for obesity have long neglected the challenge of maintenance therapy for this chronic disease. A new study in Obesity makes this gap plain to see. A […]

Are we on our way to progressing beyond weight loss as the primary end point for judging the value of new medicines in obesity? On this closing day of Obesity Care Week, topline results for a promising new obesity medicine – petrelentide – prompts us to reflect on this question. We suspect AI was making […]

Today, three of the leading voices for obesity care are releasing new guidance for obesity medicines in ongoing therapy. The Obesity Society, Obesity Medicine Association, and Obesity Action Coalition all came together in support of this important new guidance. Alongside its publication in the journal Obesity, Beverly Tchang and Donna Ryan offer a “humbling call […]

Obesity Care Week is well under way, so it’s time to take a minute to reflect upon how we frame obesity and how that matters for everyone’s health. It is instinctive to frame obesity as an issue of weight. But it is also utterly false. Though excess weight is the most prominent and visible symptom […]

Obesity Care Week (March 2–6, 2026) begins today. This is a moment when advocates, clinicians, and people living with obesity unite around a simple but profound mission: to change the way society cares for – and about – obesity. But this year, let’s be honest about the scarcity of actual caring in obesity care. We […]